Basilea Pharmaceutica Announces New Data to be Presented on Ceftobiprole and Isavuconazole at ICAAC/Infectious Diseases Society of America
BASEL, SWITZERLAND--(Marketwire - October 20, 2008) - New data on Basilea's late-stage anti-infectives ceftobiprole and isavuconazole will be presented at the upcoming joint meeting of the Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Disease Society of America (IDSA) in Washington DC.